WA HB 1019: Bill House
Washington State HB 1019 addresses regulations for AI in healthcare, impacting compliance for health systems and medical device companies.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on September 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health systems, medical device companies, health tech startups, and digital health compliance teams. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the excerpt.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New regulations regarding the use of AI in healthcare, including compliance requirements for clinical decision support and SaMD.
Who it affects
Health systems, medical device companies, health tech startups, and digital health compliance teams.
What you must do
Review and update compliance protocols to align with the new AI regulations.
Deadline
Not specified in the excerpt.
Source: https://wslwebservices.leg.wa.gov/legislationservice.asmx/GetLegislationByYear?year=2026
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- A Pathway for Clinical AI Developers Opens: FDA Clears First Software as a Medical Device With Patient-Facing LLM - McGuireWoods
- Democrats introduce bill to repeal Medicare prior authorization pilot - Healthcare Dive
- RI Senate unveils 17-bill package to improve health care - The Providence Journal
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod - fiercepharma.com
- New DOJ Compliance Program Guidance Addresses AI Risks, Use of Data Analytics - hklaw.com